These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 17643935

  • 21. Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.
    Neuhaus O, Stüve O, Archelos JJ, Hartung HP.
    J Neurol Sci; 2005 Jun 15; 233(1-2):173-7. PubMed ID: 15949504
    [Abstract] [Full Text] [Related]

  • 22. Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
    Ruggieri M, Pica C, Lia A, Zimatore GB, Modesto M, Di Liddo E, Specchio LM, Livrea P, Trojano M, Avolio C.
    J Neuroimmunol; 2008 Jul 15; 197(2):140-6. PubMed ID: 18555539
    [Abstract] [Full Text] [Related]

  • 23. Long-term treatment of multiple sclerosis with glatiramer acetate: natural history of the subtypes of anti-glatiramer acetate antibodies and their correlation with clinical efficacy.
    Karussis D, Teitelbaum D, Sicsic C, Brenner T, AC001 multi-center Israeli study group.
    J Neuroimmunol; 2010 Mar 30; 220(1-2):125-30. PubMed ID: 20153903
    [Abstract] [Full Text] [Related]

  • 24. Peptidic complex mixtures as therapeutic agents in CNS autoimmunity.
    Shukaliak Quandt J, Borras E, Prat E, Gelderblom H, Houghten RA, Kashani A, Pinilla C, Stuerzebecher CS, Martin R.
    Mol Immunol; 2004 Feb 30; 40(14-15):1075-87. PubMed ID: 15036912
    [Abstract] [Full Text] [Related]

  • 25. Prospects of repair in multiple sclerosis.
    Yong VW.
    J Neurol Sci; 2009 Feb 01; 277 Suppl 1():S16-8. PubMed ID: 19200859
    [Abstract] [Full Text] [Related]

  • 26. Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid.
    Hestvik AL, Skorstad G, Price DA, Vartdal F, Holmoy T.
    Mult Scler; 2008 Jul 01; 14(6):749-58. PubMed ID: 18611988
    [Abstract] [Full Text] [Related]

  • 27. Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.
    Lalive PH, Neuhaus O, Benkhoucha M, Burger D, Hohlfeld R, Zamvil SS, Weber MS.
    CNS Drugs; 2011 May 01; 25(5):401-14. PubMed ID: 21476611
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Glatiramer acetate (Copaxone).
    Francis DA.
    Int J Clin Pract; 2001 May 01; 55(6):394-8. PubMed ID: 11501229
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of glatiramer acetate (Copaxone) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: a longitudinal study.
    Blanco Y, Moral EA, Costa M, Gómez-Choco M, Torres-Peraza JF, Alonso-Magdalena L, Alberch J, Jaraquemada D, Arbizu T, Graus F, Saiz A.
    Neurosci Lett; 2006 Oct 09; 406(3):270-5. PubMed ID: 16934924
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The mechanism of action of glatiramer acetate treatment in multiple sclerosis.
    Racke MK, Lovett-Racke AE, Karandikar NJ.
    Neurology; 2010 Jan 05; 74 Suppl 1():S25-30. PubMed ID: 20038760
    [Abstract] [Full Text] [Related]

  • 37. Immunological assay for assessing the efficacy of glatiramer acetate (Copaxone) in multiple sclerosis. A pilot study.
    Farina C, Wagenpfeil S, Hohlfeld R.
    J Neurol; 2002 Nov 05; 249(11):1587-92. PubMed ID: 12420101
    [Abstract] [Full Text] [Related]

  • 38. Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
    Sellebjerg F, Hesse D, Limborg S, Lund H, Søndergaard HB, Krakauer M, Sørensen PS.
    Mult Scler; 2013 Feb 05; 19(2):179-87. PubMed ID: 22653658
    [Abstract] [Full Text] [Related]

  • 39. Blocking effects of serum reactive antibodies induced by glatiramer acetate treatment in multiple sclerosis.
    Salama HH, Hong J, Zang YC, El-Mongui A, Zhang J.
    Brain; 2003 Dec 05; 126(Pt 12):2638-47. PubMed ID: 12937077
    [Abstract] [Full Text] [Related]

  • 40. [Newer disease--modifying drugs: glatiramer acetate and mitoxantrone].
    Kohriyama T, Higaki M, Matsumoto M.
    Nihon Rinsho; 2003 Aug 05; 61(8):1381-7. PubMed ID: 12962027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.